Chatnekar, Guatam
- Xequel Bio, Inc. (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #3,387
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2021 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$2.1M
Full award amounts, FY2023
Award Records
1
Records listing this PI
Award-Linked Rank
#3,387
By linked amount among FY2023 PIs
Earliest Year Loaded
2021
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Chatnekar, Guatam as a PI. Multi-PI records show the full award amount for context.
- 75N93021C00009-P00006-9999-1N01Contact PIGRANEXIN AS A TOPICAL THERAPEUTIC TO MITIGATE CUTANEOUS RADIATION INJURY$2.1Maward amount
Award organization
Organizations that administered FY2023 awards listing Chatnekar, Guatam as a PI.
FY2023 award administered by Xequel Bio, Inc. (SC).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2021First NIH AwardXequel Bio, Inc.
- 2021$500K Cumulative Funding
- 2021$1M Cumulative Funding
- 2021Entered Top 50% NationallyRanked #4404
- 2021Entered Top 25% NationallyRanked #4404
- 2022$2M Cumulative Funding
- 2023$5M Cumulative Funding